25 March 2022 - The Australian Government is helping more Australians access the medications they need with a new addition to the PBS for people with progressive fibrosing interstitial lung disease.
From 1 May 2022, the PBS listing of Ofev (nintedanib) will be expanded to cover more types of progressive fibrosing interstitial lung disease.